,2 These properties suggest that it may be of therapeutic value for treatment of CF through expression of the membrane-localized CF transmembrane conductance regulator (CFTR) protein, and the vector is progressing toward a first-in-human trial. Here, CFTR is linked to cystic fibrosis.